Basaglar biosimilar?

Here’s a concise overview of Basaglar as a biosimilar insulin glargine.

- What it is
- Basaglar is a long-acting basal insulin (insulin glargine) made by Eli Lilly. It is a biosimilar to Lantus (insulin glargine).

- How it works
- It provides a steady background level of insulin over about 24 hours to help control fasting blood glucose.

- How it’s used
- Dosing: usually given once daily by subcutaneous injection. The exact dose and timing are determined by your clinician based on blood sugar, lifestyle, and other meds.
- Administration: do not mix Basaglar with other insulins in the same syringe. Use a compatible device (often a KwikPen) as prescribed.
- Titration: doses are adjusted gradually to reach target blood glucose.

- Onset and duration
- Onset of action is typically 1–2 hours after injection, with a relatively flat activity profile lasting around 24 hours.

- What it’s similar to
- Pharmacologically, Basaglar has the same active ingredient (insulin glargine) as Lantus and is designed to provide similar blood sugar control.

- Interchangeability and switching
- Basaglar is a biosimilar to Lantus. Substitution rules vary by country and local regulations. In the US, another insulin glargine product (Semglee) has been approved as interchangeable with Lantus; Basaglar itself is a biosimilar but not always designated interchangeable. Talk to your pharmacist or prescriber about switching or substitution where you live.

- Who can use it
- Indications typically include adults and some pediatric patients with type 1 or type 2 diabetes, used as the basal component of insulin therapy. Always follow your clinician’s guidance and labeling for age and dosing.

- Side effects and safety
- Common: hypoglycemia (low blood sugar), weight gain, injection-site reactions, swelling or itching.
- Rare: allergic reactions, severe hypoglycemia, lipodystrophy at injection sites.
- Important: do not use if you have low blood sugar. Monitor blood glucose closely, especially when starting or changing doses. Tell your clinician about all medications and any kidney or liver issues.

- Storage and handling
- Unopened vials or pens: refrigerate until first use.
- After first use: store at room temperature and use within the period on the label (commonly about 28 days for many insulin glargine products). Do not freeze.
- Protect from extreme heat.

If you’re considering Basaglar, or are switching from Lantus, your doctor or pharmacist can give you exact dosing, substitution rules, and storage guidance based on where you live and your treatment plan.

Would you like a quick comparison with Lantus, or guidance on switching from Lantus to Basaglar in your country?